For Kids With Cancer, Focusing on Quality of Life

For Kids With Cancer, Focusing on Quality of Life Living With Cancer By SUSAN GUBAR | NY Times | See Original Article Here JULY 27, 2017 |  Dr. Justin Baker, director of the Quality of Life and Palliative Care Division at St. Jude Children’s Research Hospital in Memphis with a patient, Emma Sarfity. CreditPeter Barta, St. Jude Children’s Research…
Continue Reading »

We Need To Raise The Bar To Improve Cancer Treatments. What’s The Best Way To Do It?

We Need To Raise The Bar To Improve Cancer Treatments. What’s The Best Way To Do It? Jacqueline Zummo| July 26, 2017 | Health Affairs Blog | See Original Article Here   Over the past 20 years, we have witnessed an unprecedented development of new life-science technologies. Although clinical outcomes have also improved, the benefits often…
Continue Reading »

Enrollment opened in pediatric cancer precision medicine trial

Enrollment opened in pediatric cancer precision medicine trial By Amy Wallace   |   July 24, 2017 at 4:12 PM | See Original Article Here The National Cancer Institute and the Children's Oncology Group are enrolling participants in the Pediatric Molecular Analysis for Therapy Choice, or Pediatric MATCH, which is a nationwide trial to explore whether targeted…
Continue Reading »

Pediatric cancer: Miracles in small packages

Pediatric cancer: Miracles in small packages CBS News | July 23, 2017 | See Original Article Here Thanks to ongoing research, the ranks of children saved from once-fatal cancers are growing by the day. Tracy Smith has a progress report. (An earlier version of this report was originally broadcast on March 12, 2017.)  When we…
Continue Reading »

Macrophages made to engulf cancer cells in solid tumors

Macrophages made to engulf cancer cells in solid tumors Date:July 19, 2017 | Source:University of Pennsylvania | See Original Article Here Summary: Human macrophages have been engineered to ignore the 'don't eat me' signal both healthy and cancerous cells exhibit. Combined with cancer-specific targeting antibodies, these engineered macrophages invaded and engulfed human tumor cells in…
Continue Reading »

Oncologists Offer Ideas To Ease Cancer’s Costs

Oncologists Offer Ideas To Ease Cancer's Costs New drugs routinely priced at $100,000 a year, ASCO says By Robert Preidt | HealthDay Reporter | WebMD | See Original Article Here WEDNESDAY, July 19, 2017 (HealthDay News) -- New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society…
Continue Reading »

Making cancer vulnerable to immune attack

Making cancer vulnerable to immune attack CRISPR-Cas9 is revealing new drug targets that could boost cancer immunotherapy July 19, 2017 |Harvard Gazette | By Kat J. McAlpine, Dana-Farber/Boston Children’s Communications | See Original Article Here Credit: Haining Lab, Dana-Farber/Boston Children's - Genetic screening for cancer immunotherapy targets cancer cells (colored shapes), each with a different…
Continue Reading »

Grass-roots Funding for E-RMS Research

There is a once-in-a-lifetime(!) opportunity for ERMS research: <; Children's Cancer Therapy Development Institute (cc-TDI) is in a unique position to raise half a million dollars specifically to develop new treatments for embryonal rhabdomyosarcoma. A donor is making a 1:1 match and will give up to $250,000 so if we reach our goal, cc-TDI could…
Continue Reading »

Should young patients with rare sarcoma subtypes be included in adult sarcoma trials?

Should young patients with rare sarcoma subtypes be included in adult sarcoma trials? HemOnc Today |  July 10, 2017 | Ian Judson | See Original Article Here Click here to read the Cover Story, “Deeper understanding of disease biology may expand sarcoma treatment options.” Yes. It is nonsense that clinical trials continue to be performed in diseases like soft…
Continue Reading »

Custom cancer vaccines safely fight and kill tumors in early human trials

Custom cancer vaccines safely fight and kill tumors in early human trials It’s early and there are many hurdles, but data so far suggests safety, efficacy. BETH MOLE - 7/6/2017, 4:06 PM | ars Technica | See Original Here Melanoma Cells With swift shots to the arm, doctors safely and effectively prime our immune systems to fight off…
Continue Reading »
Skip to toolbar